AI - Freenome

Pioneering early cancer detection through innovative next-generation blood tests using Freenome's multiomics platform.

Logo of Freenome
Last Audited At

About Freenome

Freenome is a pioneering biotech company that develops next-generation blood tests for early cancer detection. Leveraging their innovative multiomics platform, Freenome is moving early cancer detection forward, making it accessible to all. Based in South San Francisco, the team at Freenome is dedicated to decoding the means to cancer's end through clinical evidence and rigorous research. With a strong focus on accessibility, Freenome's early cancer detection blood tests aim to identify cancer in its earliest, most treatable stages. The company's commitment extends beyond their products, as they actively engage in partnerships and offer career opportunities in the field.

Screenshot of Freenome Website

Was this page helpful?

More companies

Fruition Data

Empowering businesses with AI-driven financial protection solutions for proactive identification and resolution of costly issues, enabling informed decisions and improved financial performance.

Read more

Cornami

Providing advanced encryption technologies for securing confidential data in highly regulated sectors through innovative Fully Homomorphic Encryption solutions.

Read more

Datameer

Seamlessly integrating advanced analytics solutions into modern data stacks on Snowflake, enabling quick access, collaboration, and cost savings for data teams.

Read more

Tell us about your project

Our Hubs

London, United Kingdom

A global AI hotspot, thrives on innovation, diverse talent, and a dynamic tech ecosystem, offering unparalleled opportunities for AI engineers.

Munich, Germany

A vibrant AI hub, merges cutting-edge technology with rich cultural experiences, creating an inspiring environment for AI engineers.